The AM was just 3 months ago, so it appears that Mgt must have known that it was headed toward the BascomPalmer licensing arrangement (PDAT). Additionally, the recent posting of info related to PDT/RB usage in Breast Cancer cases seems to confirm that PDT/RB is an approach with much potential.
So, how does PDAT and PDT portend for the companies main product, PV-10?
Is it a brand new road opening...or is it serious competition?
Mgt has worked hard to patent many aspects of PV-10, but I don't know if unprocessed RB is a serious threat to PV-10.